Clinical Trial Update: Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update covers a Phase 2/3 study of a combined modality therapy for adenocarcinoma of the gastroesophageal junction, focusing on efficacy and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction

Snippet

Sponsor: Medical University of Lublin | Conditions: Adenocarcinoma of the Gastroesophageal Junction | Phase 2, Phase 3 | Status: UNKNOWN